http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2301643-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4ff32fc4899c35c85145a19bcbdee5e |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-067 |
filingDate | 2005-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2007-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_902476a64913eda5733c2acfe952f8f1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acafa361a05178729b36da68593887fe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61aa94655046c88dea08adc7b34de50f |
publicationDate | 2007-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2301643-C1 |
titleOfInvention | Method for treating uveitis cases of unclear and virus etiology using laser blood irradiation |
abstract | FIELD: medicine. n SUBSTANCE: method involves exposing blood to pulsating intravenous laser radiation of 2 W power. Pulse duration is 260 ns, pulse succession frequency is 10000Hz, wavelength is 0.89 mcm and action time is 15 min. n EFFECT: accelerated treatment course; excluded adverse side effects; reduced toxin concentration in blood. |
priorityDate | 2005-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.